THE DERMATOPROTECTIVE ACTIVITY OF DIMEPHOSPHON BY REDUCED BLOOD CIRCULATION WITHIN THE SKIN ON THE BACKGROUND OF THE EXPERIMENTAL DIABETES MELLITUS AND THE EXOGENOUS HYPERCHOLESTEROLEMIA

Aim. The study of Dimephosphon impact on survival of the dermal graft on the pedicle and the fasciocutaneous autograft in the arterial, venous and arteriovenous deficiency on the background of the experimental diabetes mellitus complicated by exogenous hypercholesterolemia.

Material and Methods. In experiments on white rat males with Alloxan diabetes complicated by exogenous hypercholesterolemia the Dimephosphon effect was estimated for survival of the dermal graft on the pedicle (in the back area) and non-free fasciocutaneous autograft (of the anterior abdominal wall) in arterial, venous and arteriovenous circulation deficiency. To estimate dermatoprotective action of Dimephosphon the length the survived dermal draft part and the necrotic area of the non-free fasciocutaneous autograft were measured. In blood serum the glucose rate (by glucose oxidant method with a standard “Glucose-FKD” (Russia) reagents set ), as well as the total cholesterol , triglyceride, high-density lipoprotein cholesterol rate (by “Olmex” standard reagent sets on the FP-901 (Finland) analyzer ) were measured. Extralow and low density lipoprotein cholesterol and also atherogenicity index were calculated with common formulas.

Results. Under accepted experimental conditions Dimephosphon (100mg/kg per day subcutaneously within 14 days) has well-defined dermatoprotective action as well as correcting effect on carbohydrate and lipid metabolism.

Conclusion. Dimephosphon dermatoprotective action can be provided by its ability to be involved in various parts of homeostasis including carbohydrate and lipid metabolism.

1. Nefedov D.A., Zelenskaya A.V. Dubova M.S., Chaiyeva A.S., Galenko-Yaroshevsky P.A. The effect of combined local and intravenous dimephosphon application on the Ischemic dermal draft viability and free autograft engraftment. Kuban Scientific Medical Journal. 2015. No 6. (155). P. 93-100. (In Russ.)

2. Nefedov D.A., Zelenskaya A.V., Kopitsa V.V., Timakova O.A., Hananashvili Y.A., Galenko-Yaroshevsky P.A.. Comparative study of Dimephosphon, Actovegin and Trental effect on viability of fasciocutaneous autograft in arterial circulation deficiency and venous stasis. Kuban Scientific Medical Journal. 2016. No 3 (158). P. 102- 108. (In Russ.)

3. Nefedov D.A., Zelenskaya A.V., Sabirova N.A., Galenko-Yaroshevsky P.A. Dimephosphon dermatoprotective activity in reduced blood circulation. Kuban Scientific Medical Journal. 2015. No 5 (154). P. 99-106. (In Russ.)

4. Balabolkin M.I., Klebanova E.M., Kreminskaya V.M. Pathogenesis and angiopathy development mechanism in diabetes mellitus. Cardiology. 2000, No. 10, Р. 74-84. (In Russ.)

5. Saltikov B.B. Development mechanisms of diabetic macroangiopathy. Cardiology. 2001. No 4. P. 21-25. (In Russ.)

6. Tronko N.D., Yefimov A.S., Slavkov V.N., Markov V.V., Zubkova G.A., Kovpak N.A., Zemlyanskaya S.V., Sakharova Y.V. Diabetic angiopathy radionuclide diagnostics. Ukraine AMS Journal. 2002. Vol 8. No 3. P. 522- 534. (In Russ.)

7. Lubimov B.I., Samoyov N.N. Kizhayev E.V., Babaniyazov H.H., Yakushin V.I., Barachevsky Y.E., Kahramanov V.U. Methodological recommendations for quantitative assessment of drug effect on tissue viability in reduced blood circulation. M. 1986. 12 p. (In Russ.)

8. Kizhayev E.V., Nerobeyev A.I., Kahramanov V.U., Sholokhov V.M. Pharmacological protection of the graft in arterial circulation deficiency or venous stasis. Specialized medical care and modern problems of its integration M. 1986. P. 373- 374. (In Russ.)

9. Zelenskaya A.V., Galenko-Yaroshevsky P.A. Reamberin and Recsod. Pharmacological correction of reduced blood circulation of the skin in diabetes mellitus. Krasnodar. Prosveschenye-Yug Publ. 2013. 202 p. (In Russ.)

10. Slivkin A.I., Chernov Y.N., Buzlama A.V. Pallet for planimetric measuring of objects in biology and medicine. RF Utility Model Patent N 114147, publ. 10.03.2012, Bul. No 7. (In Russ.)

11. Smirnov L.D., Incina V.I., Kostin Y.V., Kokoreva E.V., Bogolubova J.V. Possiblities of Antioxydant pharmagological correction for metabolic disorders in diabetes mellitus. Biomedical chemistry. 2004. Vol.50, Р. 502-508. (In Russ.)

12. Vizel A.O., Garayev R.S. A new aspect of the pharmacological approach to phosphorus compounds. Dimephosphon. Kazan: “Pechat-Servis-21 vek” Publ. 2012. 189 p. (In Russ.)

13. Malishev V.G., Fedoseykin I.V. Dimephosphon effect on the body homeostasis. M. Nauka. 2007. 213 p. (In Russ.)

14. Shahmardanova S.A., Gulevskaya O.N., Seletskaya V.V., Zelenskaya A.V., Hananashvili Y.A., Nefedov D.A., Galenko-Yaroshevsky P.A. Antioxydants: classification, pharmacotherapeutic properties, application in practical medicine. Journal of Fundamental Medicine and Biology. 2016. No 3. P. 4-15. (In Russ.).